ANDREW L MAMMEN

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
    ANDREW L MAMMEN
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arthritis Rheum 63:713-21. 2011
  2. ncbi Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy
    ANDREW L MAMMEN
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arthritis Care Res (Hoboken) 64:1233-7. 2012
  3. ncbi Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle
    ANDREW L MAMMEN
    Johns Hopkins Bayview, Johns Hopkins Myositis Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Arthritis Rheum 60:3784-93. 2009
  4. ncbi Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis
    ANDREW L MAMMEN
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ann N Y Acad Sci 1184:134-53. 2010
  5. ncbi Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis
    ANDREW L MAMMEN
    Department of Neurology, Johns Hopkins Bayview Medical Center, Johns Hopkins Myositis Center, Mason F Lord Building Center Tower, Suite 4500, Baltimore, MD 21224, USA USA
    Nat Rev Neurol 7:343-54. 2011
  6. ncbi Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects
    ANDREW L MAMMEN
    Johns Hopkins University, Baltimore, Maryland, USA
    Arthritis Care Res (Hoboken) 64:269-72. 2012
  7. ncbi Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy
    Jessie L Werner
    Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Arthritis Rheum 64:4087-93. 2012
  8. ncbi A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy
    Lisa Christopher-Stine
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arthritis Rheum 62:2757-66. 2010
  9. ncbi Isolated elevation of aldolase in the serum of myositis patients: a potential biomarker of damaged early regenerating muscle cells
    Livia Casciola-Rosen
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Clin Exp Rheumatol 30:548-53. 2012
  10. ncbi Myositis autoantibodies
    Livia Casciola-Rosen
    Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21224, USA
    Curr Opin Rheumatol 24:602-8. 2012

Collaborators

Detail Information

Publications14

  1. ncbi Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
    ANDREW L MAMMEN
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arthritis Rheum 63:713-21. 2011
    ..The purpose of this study was to identify these molecules to help clarify the disease mechanism and facilitate diagnosis...
  2. ncbi Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy
    ANDREW L MAMMEN
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arthritis Care Res (Hoboken) 64:1233-7. 2012
    ..To investigate the association of anti-hydroxymethylglutaryl-coenzyme A reductase (anti-HMGCR) myopathy with HLA class I and II antigens...
  3. ncbi Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle
    ANDREW L MAMMEN
    Johns Hopkins Bayview, Johns Hopkins Myositis Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Arthritis Rheum 60:3784-93. 2009
    ..This study was undertaken to define the population of cells expressing high levels of Mi-2 in DM muscle and to explore the regulation and functional role of Mi-2 during muscle regeneration...
  4. ncbi Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis
    ANDREW L MAMMEN
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ann N Y Acad Sci 1184:134-53. 2010
    ....
  5. ncbi Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis
    ANDREW L MAMMEN
    Department of Neurology, Johns Hopkins Bayview Medical Center, Johns Hopkins Myositis Center, Mason F Lord Building Center Tower, Suite 4500, Baltimore, MD 21224, USA USA
    Nat Rev Neurol 7:343-54. 2011
    ..The contribution of interferon signaling to the development of dermatomyositis and the potential link between malignancies and the initiation of autoimmune myopathies are also assessed...
  6. ncbi Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects
    ANDREW L MAMMEN
    Johns Hopkins University, Baltimore, Maryland, USA
    Arthritis Care Res (Hoboken) 64:269-72. 2012
    ..The current work assessed the prevalence of anti-HMGCR antibodies in these groups of statin users...
  7. ncbi Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy
    Jessie L Werner
    Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Arthritis Rheum 64:4087-93. 2012
    ..The main objective of this study was to define the association of anti-HMGCR antibody levels with disease activity...
  8. ncbi A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy
    Lisa Christopher-Stine
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arthritis Rheum 62:2757-66. 2010
    ..The aim of this study was to identify novel autoantibodies in patients with necrotizing myopathy...
  9. ncbi Isolated elevation of aldolase in the serum of myositis patients: a potential biomarker of damaged early regenerating muscle cells
    Livia Casciola-Rosen
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Clin Exp Rheumatol 30:548-53. 2012
    ..Elevated serum aldolase A levels occur in the absence of elevated creatine kinase M (CK) levels in a subset of myositis patients. This study was undertaken to investigate the cell biology of this unexplained clinical observation...
  10. ncbi Myositis autoantibodies
    Livia Casciola-Rosen
    Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21224, USA
    Curr Opin Rheumatol 24:602-8. 2012
    ..To review recent advances in our understanding of autoantibodies associated with dermatomyositis and the autoimmune necrotizing myopathies...
  11. ncbi Magnetic resonance imaging of inflammatory myopathies
    Filippo Del Grande
    Russell H Morgan Department of Radiology and Radiological Science, School of Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA
    Top Magn Reson Imaging 22:39-43. 2011
    ..Lastly, we provide an overview about some advanced MRI techniques that focus more on function than on morphology of muscle...
  12. ncbi A novel conserved isoform of the ubiquitin ligase UFD2a/UBE4B is expressed exclusively in mature striated muscle cells
    ANDREW L MAMMEN
    Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheumatology, Baltimore, Maryland, United States of America
    PLoS ONE 6:e28861. 2011
    ..We conclude that the regulated expression of these UFD2a isoforms most likely imparts divergent functions that are important for myogenisis...
  13. ncbi Expanding the spectrum of monoclonal light chain deposition disease in muscle
    Lyle W Ostrow
    Department of Neurology, Johns Hopkins School of Medicine, 733 N Broadway, Baltimore, Maryland 21205, USA
    Muscle Nerve 45:755-61. 2012
    ..The diagnosis of amyloid myopathy is delayed when monoclonal gammopathies are not detected on initial testing and muscle biopsies are nondiagnostic, and the EMG and symptoms can mimic an inflammatory myopathy...
  14. ncbi Statin myopathy: a review of recent progress
    ANDREW L MAMMEN
    Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Curr Opin Rheumatol 22:644-50. 2010
    ..However, they can have myotoxic effects ranging in severity from myalgias to rhabdomyolysis. This review focuses on recent progress in defining the clinical features and mechanism(s) of statin-induced myopathy...